ClinicalTrials.govpublic full text
GLP-1R Actions on Muscle and the Skeleton
musculoskeletal abnormalities, obesity, sarcopenic obesity, osteoporosis, drug effect, glp-1 agonists, obesity treatments, muscleskeletal loss, tirzepatide, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882528
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.